Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ABIO

ARCA biopharma (ABIO) Stock Price, News & Analysis

ARCA biopharma logo

About ARCA biopharma Stock (NASDAQ:ABIO)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$2.40
$599.04
52-Week Range
N/A
Volume
290,800 shs
Average Volume
607,995 shs
Market Capitalization
$34.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ABIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ARCA biopharma and its competitors with MarketBeat's FREE daily newsletter.

ABIO Stock News Headlines

$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
See More Headlines

ABIO Stock Analysis - Frequently Asked Questions

ARCA biopharma, Inc. (NASDAQ:ABIO) released its quarterly earnings data on Wednesday, August, 4th. The biopharmaceutical company reported ($48.96) earnings per share (EPS) for the quarter, topping the consensus estimate of ($341.28) by $292.32.

ARCA biopharma's stock reverse split on Tuesday, September 3rd 2024.The 1-12 reverse split was announced on Friday, August 23rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, August 30th 2024. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that ARCA biopharma investors own include Digital Turbine (APPS), Vuzix (VUZI), Canoo (GOEV), ChargePoint (CHPT) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
8/04/2021
Today
7/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Diagnostic substances
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ABIO
CIK
907654
Employees
6
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.42)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$5.34 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-20.18%
Return on Assets
-19.51%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
26.61
Quick Ratio
26.61

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.25 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
14,507,000
Free Float
10,024,000
Market Cap
$34.82 million
Optionable
Optionable
Beta
0.91
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:ABIO) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners